Chimerix, Inc.
CMRX
$8.54
-$0.01-0.12%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 212.00K | 159.00K | 144.00K | 41.00K | 324.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 212.00K | 159.00K | 144.00K | 41.00K | 324.00K |
| Cost of Revenue | 79.36M | 78.33M | 75.69M | 74.19M | 72.67M |
| Gross Profit | -79.15M | -78.17M | -75.55M | -74.15M | -72.34M |
| SG&A Expenses | 22.71M | 20.92M | 25.05M | 24.97M | 24.60M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 98.78M | 94.98M | 96.87M | 95.28M | 93.39M |
| Operating Income | -98.57M | -94.83M | -96.72M | -95.24M | -93.07M |
| Income Before Tax | -88.39M | -83.59M | -84.70M | -82.59M | -82.10M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -88.39 | -83.59 | -84.70 | -82.59 | -82.10 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -88.39M | -83.59M | -84.70M | -82.59M | -82.10M |
| EBIT | -98.57M | -94.83M | -96.72M | -95.24M | -93.07M |
| EBITDA | -98.47M | -94.74M | -96.63M | -95.15M | -92.97M |
| EPS Basic | -0.99 | -0.94 | -0.95 | -0.93 | -0.93 |
| Normalized Basic EPS | -0.63 | -0.60 | -0.61 | -0.60 | -0.58 |
| EPS Diluted | -0.99 | -0.94 | -0.95 | -0.93 | -0.93 |
| Normalized Diluted EPS | -0.63 | -0.60 | -0.61 | -0.60 | -0.58 |
| Average Basic Shares Outstanding | 358.85M | 357.50M | 356.42M | 355.37M | 354.41M |
| Average Diluted Shares Outstanding | 358.85M | 357.50M | 356.42M | 355.37M | 354.41M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |